StockData
NEUROONE MEDICAL TECHNOLOGIES Corp logo

NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) stock

NMTCNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 11/3079% below fair value
$0.71−0.04 (-5.15%)

Close on Nov 17, 2026Market cap $6.43MP/E –Yield –

Neuroone Medical Technologies cash

Cash and short-term investments held at the end of each period.

Neuroone Medical Technologies's cash was $2.05M at Jun 30, 2026. For fiscal 2025 it was $6.57M, up 350.0% from the year before. Over ten years it grew 156.9% a year on average. The highest annual figure on record is $11.14M in fiscal 2022.

Annual cash

PeriodPeriod endValueChange
FY2025Sep 30, 2025$6.57M+350.0%
FY2024Sep 30, 2024$1.46M-72.6%
FY2023Sep 30, 2023$5.32M-52.2%
FY2022Sep 30, 2022$11.14M+61.4%
FY2021Sep 30, 2021$6.90M+71.0%
FY2020Sep 30, 2020$4.04M+15150.7%
FY2017Dec 31, 2017$26.47K-94.9%
FY2016Dec 31, 2016$522.22K–
FY2015Dec 31, 2015$0-100.0%
FY2014Dec 31, 2014$205-61.0%
FY2013Dec 31, 2013$525-53.0%
FY2012Dec 31, 2012$1.12K-91.9%
FY2011Dec 31, 2011$13.85K+51.7%
FY2010Dec 31, 2010$9.13K–

Quarterly cash

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q3 FY2026CQ2 2026Jun 30, 2026$2.05M-74.5%
Q2 FY2026CQ1 2026Mar 31, 2026$2.80M+112.4%
Q1 FY2026CQ4 2025Dec 31, 2025$3.56M+214.0%
Q4 FY2025CQ3 2025Sep 30, 2025$6.57M+350.0%
Q3 FY2025CQ2 2025Jun 30, 2025$8.04M+396.3%
Q2 FY2025CQ1 2025Mar 31, 2025$1.32M-45.8%
Q1 FY2025CQ4 2024Dec 31, 2024$1.13M-57.7%
Q4 FY2024CQ3 2024Sep 30, 2024$1.46M-72.6%
Q3 FY2024CQ2 2024Jun 30, 2024$1.62M-47.5%
Q2 FY2024CQ1 2024Mar 31, 2024$2.43M-47.0%
Q1 FY2024CQ4 2023Dec 31, 2023$2.68M-64.9%
Q4 FY2023CQ3 2023Sep 30, 2023$5.32M-52.2%
Q3 FY2023CQ2 2023Jun 30, 2023$3.08M-69.7%
Q2 FY2023CQ1 2023Mar 31, 2023$4.60M-64.3%
Q1 FY2023CQ4 2022Dec 31, 2022$7.64M-52.8%
Q4 FY2022CQ3 2022Sep 30, 2022$11.14M+61.4%
Q3 FY2022CQ2 2022Jun 30, 2022$10.18M+13.2%
Q2 FY2022CQ1 2022Mar 31, 2022$12.87M+14.1%
Q1 FY2022CQ4 2021Dec 31, 2021$16.18M+127.0%
Q4 FY2021CQ3 2021Sep 30, 2021$6.90M+71.0%
Q3 FY2021CQ2 2021Jun 30, 2021$8.99M+135.1%
Q2 FY2021CQ1 2021Mar 31, 2021$11.27M+1408.8%
Q1 FY2021CQ4 2020Dec 31, 2020$7.13M+248.7%
Q4 FY2020CQ3 2020Sep 30, 2020$4.04M+15150.7%
Q3 FY2020CQ2 2020Jun 30, 2020$3.82M+5360.5%
Q2 FY2020CQ1 2020Mar 31, 2020$747.24K+53.6%
Q1 FY2020CQ4 2019Dec 31, 2019$2.04M+320.3%
Q4 FY2017CQ4 2017Dec 31, 2017$26.47K-94.9%
Q3 FY2017CQ3 2017Sep 30, 2017$70.03K–
Q2 FY2017CQ2 2017Jun 30, 2017$486.42K–
Q1 FY2017CQ1 2017Mar 31, 2017$486.42K–
Q4 FY2016CQ4 2016Dec 31, 2016$522.22K–
Q3 FY2016CQ3 2016Sep 30, 2016$0–
Q2 FY2016CQ2 2016Jun 30, 2016$0–
Q1 FY2016CQ1 2016Mar 31, 2016$0-100.0%
Q4 FY2015CQ4 2015Dec 31, 2015$0-100.0%
Q3 FY2015CQ3 2015Sep 30, 2015$0–
Q2 FY2015CQ2 2015Jun 30, 2015$0–
Q1 FY2015CQ1 2015Mar 31, 2015$195–
Q4 FY2014CQ4 2014Dec 31, 2014$205–

More Neuroone Medical Technologies figures

See a number that looks wrong?